(Q50801058)

19 March 2018

title

Ovarian cancer screening with annual transvaginal sonography: findings of 25,000 women screened. (English)

1 reference

19 March 2018

1 reference

John R van Nagell

1

1 reference

19 March 2018

Paul D DePriest

2

1 reference

19 March 2018

Frederick R Ueland

3

1 reference

19 March 2018

Christopher P DeSimone

4

1 reference

19 March 2018

Amy L Cooper

5

1 reference

19 March 2018

J Matt McDonald

6

1 reference

19 March 2018

Edward J Pavlik

7

1 reference

19 March 2018

Richard J Kryscio

8

1 reference

19 March 2018

language of work or name

English

0 references

publication date

1 May 2007

1 reference

19 March 2018

number of pages

10

1 reference

inferred from page(s)

published in

Cancer

1 reference

19 March 2018

volume

109

1 reference

19 March 2018

issue

9

1 reference

19 March 2018

page(s)

1887-1896

1 reference

19 March 2018

Risk of diagnosis of ovarian cancer after raised serum CA 125 concentration: a prospective cohort study

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22594

Breast cancer screening: a summary of the evidence for the U.S. Preventive Services Task Force

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22594

21 January 2018

Cancer statistics, 2005

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22594

7 January 2021

The accuracy of examination under anesthesia and transvaginal sonography in evaluating ovarian size

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22594

7 January 2021

Adjuvant therapy in stage I and stage II epithelial ovarian cancer. Results of two prospective randomized trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22594

7 January 2021

Transabdominal ultrasound screening for early ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22594

7 January 2021

Transvaginal sonography as a screening method for ovarian cancer. A report of the first 1000 cases screened

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22594

7 January 2021

Multimodal approach to screening for ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22594

7 January 2021

Screening for early familial ovarian cancer with transvaginal ultrasonography and colour blood flow imaging.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22594

7 January 2021

Transvaginal sonography as a screening method for the detection of early ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22594

7 January 2021

Screening for ovarian cancer: a pilot randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22594

7 January 2021

Usefulness of mass screening for ovarian carcinoma using transvaginal ultrasonography.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22594

7 January 2021

The efficacy of transvaginal sonographic screening in asymptomatic women at risk for ovarian cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22594

7 January 2021

Ovarian cancer screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial: Findings from the initial screen of a randomized trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22594

7 January 2021

Ovarian volume related to age.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22594

7 January 2021

Preoperative differentiation of malignant from benign ovarian tumors: the efficacy of morphology indexing and Doppler flow sonography

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22594

7 January 2021

Participation in transvaginal ovarian cancer screening: compliance, correlation factors, and costs

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22594

7 January 2021

Continuing participation supports ultrasound screening for ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22594

7 January 2021

Interobserver variation in ovarian measurements using transvaginal sonography

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22594

7 January 2021

Cancer screening. Degrees of proof and practical application

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22594

7 January 2021

A morphology index based on sonographic findings in ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22594

7 January 2021

The malignant potential of small cystic ovarian tumors in women over 50 years of age

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22594

7 January 2021

Preoperative evaluation of serum CA 125 levels in premenopausal and postmenopausal patients with pelvic masses. Discrimination of benign from malignant disease

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22594

7 January 2021

Prospective multicenter study on CA 125 in postmenopausal pelvic masses

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22594

7 January 2021

Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22594

7 January 2021

Calculation of the risk of ovarian cancer from serial CA-125 values for preclinical detection in postmenopausal women.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22594

7 January 2021

Use of a stochastic simulation model to identify an efficient protocol for ovarian cancer screening

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22594

7 January 2021

Use of proteomic patterns in serum to identify ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22594

7 January 2021

Lessons from controversy: ovarian cancer screening and serum proteomics.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22594

7 January 2021

Intraperitoneal cisplatin and paclitaxel in ovarian cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22594

7 January 2021

Identifiers

DOI

10.1002/CNCR.22594

1 reference

19 March 2018

PubMed ID

17373668

1 reference

19 March 2018